About Relay Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://relaytx.com/
Frequently Asked Questions
What is the 52-week range for RLAY?
The 52-week high is $21.27 and the 52-week low is $5.165.
What is the P/E ratio for RLAY?
The P/E ratio data is currently unavailable.
What is the dividend yield for RLAY?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -42.27%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -2047.23%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.59.
Analyst Recommendation Trends
Wall Street analyst consensus for RLAY over the last few months:
Latest RLAY News
Raymond James Updates Healthcare Top Picks for October
Investing.com -- Raymond James has updated its Healthcare Top Picks list for October, adding three new stocks while removing others from the monthly selection. The firm added Xencor, Calyxt, and UnitedHealth Group to replace Relay Therapeutics, Tyra Biosciences, and Oscar Health.
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
RXRX's strategic partnerships are expanding its drug pipeline, strengthening AI capabilities and providing non-dilutive funding through early 2028.
X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics
WALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- X-Chem, a global leader in innovative drug discovery services, announced the achievement of a milestone following Relay Therapeutics’ initiation of a Phase 3 clinical trial of a drug candidate developed from a compound identified through an X-Chem DNA-encoded chemical library (DEL) screen. Relay Therapeutics, a leader in cutting-edge approaches to drug discovery, licensed an inhibitor of the oncology target phosphoinositide 3- kinase alpha (Pl3K
Relay Therapeutics, Inc. (RLAY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Relay Therapeutics, Inc. (RLAY) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 9:15 AM EDTCompany ParticipantsSanjiv Patel -...
Relay Therapeutics, Inc. (RLAY) Presents at Wells Fargo 21st Annual Healthcare Conference Prepared Remarks Transcript
Relay Therapeutics, Inc. (RLAY) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 1:30 PM EDTCompany ParticipantsPeter Rahmer - Chief...
Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook?
Recursion Pharmaceuticals is expanding its clinical pipeline across oncology and rare diseases, with REC-4881 and multiple programs offering potential growth catalysts.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-08 | Catinazzo Thomas | -17,717 | $18.94 | $335,560 |
| 2026-09-08 | Patel Sanjiv | -48,199 | $18.94 | $912,889 |
| 2026-09-08 | Bergstrom Donald A | -8,530 | $18.97 | $161,814 |
| 2026-08-26 | Rahmer Peter | -4,508 | $20.03 | $90,295 |
| 2026-08-25 | SVF Pauling (Cayman) Ltd | -6,000,000 | $19.4 | $116,400,000 |
| 2026-08-17 | Patel Sanjiv | -48,199 | $20.33 | $979,886 |
| 2026-08-14 | Catinazzo Thomas | -17,717 | $19.74 | $349,734 |
| 2026-07-28 | Catinazzo Thomas | -1,459 | $18.61 | $27,152 |
| 2026-07-28 | Rahmer Peter | -748 | $18.61 | $13,920 |
| 2026-07-28 | Bergstrom Donald A | -2,237 | $18.61 | $41,631 |
| 2026-07-07 | Patel Sanjiv | -48,199 | $19.58 | $943,736 |
| 2026-07-06 | Catinazzo Thomas | -17,717 | $18.69 | $331,131 |
| 2026-07-06 | Bergstrom Donald A | -8,660 | $18.71 | $162,029 |
| 2026-06-30 | Patel Sanjiv | +3,056 | $6.95 | $21,239 |
| 2026-06-30 | Rahmer Peter | +3,056 | $6.95 | $21,239 |
| 2026-06-30 | Rahmer Peter | -50,000 | $19.09 | $954,500 |
| 2026-06-22 | Catinazzo Thomas | -51,560 | - | - |
| 2026-06-22 | Catinazzo Thomas | -61,563 | - | - |
| 2026-06-22 | Catinazzo Thomas | -56,323 | - | - |
| 2026-06-22 | Catinazzo Thomas | -51,560 | $16.97 | $874,973 |
| 2026-06-22 | Catinazzo Thomas | +51,560 | $4.45 | $229,442 |
| 2026-06-22 | Catinazzo Thomas | -61,563 | $16.97 | $1,044,724 |
| 2026-06-22 | Catinazzo Thomas | +61,563 | $5.22 | $321,359 |
| 2026-06-22 | Catinazzo Thomas | -56,323 | $16.97 | $955,801 |
| 2026-06-22 | Catinazzo Thomas | +56,323 | $5.04 | $283,868 |
| 2026-06-22 | Catinazzo Thomas | -17,717 | $17.01 | $301,366 |
| 2026-06-22 | Bergstrom Donald A | -93,456 | - | - |
| 2026-06-22 | Bergstrom Donald A | -93,456 | $16.94 | $1,583,145 |
| 2026-06-22 | Bergstrom Donald A | +93,456 | $4.12 | $385,039 |
| 2026-06-09 | Mazumdar Claire | +32,947 | - | - |
| 2026-06-09 | Murcko Mark | +32,947 | - | - |
| 2026-06-09 | Dable Habib J | +32,947 | - | - |
| 2026-06-09 | COATS LONNEL | +32,947 | - | - |
| 2026-06-09 | Borisy Alexis | +32,947 | - | - |
| 2026-06-09 | INGRAM DOUGLAS S | +32,947 | - | - |
| 2026-06-09 | HILL LINDA A | +32,947 | - | - |
| 2026-05-14 | Catinazzo Thomas | -17,717 | $12.86 | $227,841 |
| 2026-04-28 | Bergstrom Donald A | -1,490 | $14.79 | $22,037 |
| 2026-04-28 | Catinazzo Thomas | -972 | $14.79 | $14,376 |
| 2026-04-28 | Rahmer Peter | -753 | $14.79 | $11,137 |
| 2026-04-09 | Catinazzo Thomas | -1,800 | - | - |
| 2026-04-09 | Catinazzo Thomas | -1,800 | $15 | $27,000 |
| 2026-04-09 | Catinazzo Thomas | +1,800 | $5.22 | $9,396 |
| 2026-04-07 | Catinazzo Thomas | -17,717 | $13.01 | $230,498 |
| 2026-03-09 | Catinazzo Thomas | -17,717 | $10.06 | $178,233 |
| 2026-01-28 | Rahmer Peter | -1,354 | $8.45 | $11,441 |
| 2026-01-28 | Catinazzo Thomas | -1,695 | $8.45 | $14,323 |
| 2026-01-28 | Bergstrom Donald A | -2,686 | $8.45 | $22,697 |
| 2026-01-27 | Rahmer Peter | -11,684 | $7.62 | $89,032 |
| 2026-01-27 | Catinazzo Thomas | -13,820 | $7.62 | $105,308 |
| 2026-01-27 | Bergstrom Donald A | -18,895 | $7.62 | $143,980 |
| 2026-01-13 | Rahmer Peter | +475,000 | - | - |
| 2026-01-13 | Patel Sanjiv | +1,450,000 | - | - |
| 2026-01-13 | Catinazzo Thomas | +400,000 | - | - |
| 2026-01-13 | Bergstrom Donald A | +575,000 | - | - |
| 2026-01-06 | Patel Sanjiv | -43,168 | $7.82 | $337,574 |
| 2025-12-31 | Rahmer Peter | +994 | $2.99 | $2,972 |
| 2025-12-31 | Patel Sanjiv | +994 | $2.99 | $2,972 |
| 2025-11-04 | COATS LONNEL | +207,931 | - | - |
| 2025-11-04 | Dable Habib J | +207,931 | - | - |
| 2025-11-03 | Patel Sanjiv | -62,073 | $7 | $434,511 |
| 2025-10-29 | Rahmer Peter | -21,394 | $7.5 | $160,455 |
| 2025-10-28 | Rahmer Peter | -19,135 | $7.29 | $139,494 |
| 2025-10-28 | Catinazzo Thomas | -21,664 | $7.29 | $157,931 |
| 2025-10-28 | Bergstrom Donald A | -30,897 | $7.29 | $225,239 |